Bioventus Inc.

BVS Q2 2026 Earnings: Bioventus Edges Past EPS Estimate as Shares Gain 2.3% - Earnings Quality Score
https://www.dars.gov.et/ · 16 Oct 2026
The Bet Bioventus Holders Made Before An 82% Jump
Simply Wall Street · 07 Oct 2026
Bioventus: The Tax Line Steals the Show
Orthopedics This Week · 30 Sep 2026
Bioventus Inc. (NASDAQ:BVS) Stock Now Rated "Moderate Buy" by Wall Street Analysts
MarketBeat · 28 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.